170 related articles for article (PubMed ID: 35960614)
1. Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality.
Cheng MH; Ho OA; Tsai TJ; Lin YL; Kuo CF
J Surg Oncol; 2022 Dec; 126(7):1162-1168. PubMed ID: 35960614
[TBL] [Abstract][Full Text] [Related]
2. Surgical-Site Infection is Associated With Increased Risk of Breast Cancer-Related Lymphedema: A Nationwide Cohort Study.
Jørgensen MG; Gözeri E; Petersen TG; Sørensen JA
Clin Breast Cancer; 2023 Jul; 23(5):e296-e304.e2. PubMed ID: 37095025
[TBL] [Abstract][Full Text] [Related]
3. Impact of risk factors, early rehabilitation and management of lymphedema associated with breast cancer: a retrospective study of breast Cancer survivors over 5 years.
Tomić S; Malenković G; Mujičić E; Šljivo A; Tomić SD
BMC Womens Health; 2024 Apr; 24(1):226. PubMed ID: 38582869
[TBL] [Abstract][Full Text] [Related]
4. The critical role of phlebolymphedema in cellulitis associated with lymphedema: Its incidence and economic impact in a large real-world population.
Tedesco A; O'Donnell T; Weycker D; Salehi P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101704. PubMed ID: 37977518
[TBL] [Abstract][Full Text] [Related]
5. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements.
Shah C; Zambelli-Weiner A; Delgado N; Sier A; Bauserman R; Nelms J
Breast Cancer Res Treat; 2021 Feb; 185(3):709-740. PubMed ID: 33245458
[TBL] [Abstract][Full Text] [Related]
6. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
7. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
[TBL] [Abstract][Full Text] [Related]
8. Weight loss does not decrease risk of breast cancer-related arm lymphedema.
Roberts SA; Gillespie TC; Shui AM; Brunelle CL; Daniell KM; Locascio JJ; Naoum GE; Taghian AG
Cancer; 2021 Nov; 127(21):3939-3945. PubMed ID: 34314022
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Risk Factors of Breast Cancer-Related Lymphedema and Construction and Evaluation of a Prediction Model.
Li H; Li WB; Sun ZX; Yu J; Lv PY; Li CX; Liang X; Yu Y; Zhao ZB
Lymphat Res Biol; 2023 Dec; 21(6):565-573. PubMed ID: 37768813
[No Abstract] [Full Text] [Related]
10. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prediction model for persistent breast-cancer-related lymphedema: a 5-year cohort study.
Penn IW; Chang YC; Chuang E; Chen CM; Chung CF; Kuo CY; Chuang TY
Support Care Cancer; 2019 Mar; 27(3):991-1000. PubMed ID: 30105666
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
[TBL] [Abstract][Full Text] [Related]
13. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis.
Johansson K; Branje E
Acta Oncol; 2010; 49(2):166-73. PubMed ID: 20100154
[TBL] [Abstract][Full Text] [Related]
14. Weight Gain and Lymphedema After Breast Cancer Treatment: Avoiding the Catch-22?
Boyages J; Cave AE; Naidoo D; Ee CCL
Lymphat Res Biol; 2022 Aug; 20(4):409-416. PubMed ID: 34748426
[No Abstract] [Full Text] [Related]
15. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
[No Abstract] [Full Text] [Related]
16. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
[TBL] [Abstract][Full Text] [Related]
17. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
18. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.
Kwan ML; Yao S; Lee VS; Roh JM; Zhu Q; Ergas IJ; Liu Q; Zhang Y; Kutner SE; Quesenberry CP; Ambrosone CB; Kushi LH
Breast Cancer Res Treat; 2016 Aug; 159(1):119-29. PubMed ID: 27449493
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of Primary Care Physicians About Breast-Cancer-Related Lymphedema: Turkish Perspective.
Mete Civelek G; Aypak C; Turedi O
J Cancer Educ; 2016 Dec; 31(4):687-692. PubMed ID: 26159749
[TBL] [Abstract][Full Text] [Related]
20. Combining reconstructive and ablative surgical treatment of chronic breast cancer-related lymphedema (BCRL): safe and effective.
Ghazaleh AA; Handschin TM; Buckowiecki J; Chammartin FS; Andree C; Schaefer DJ; Haug M; Kappos EA; Seidenstuecker K
Breast Cancer Res Treat; 2023 Jan; 197(1):83-92. PubMed ID: 36287309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
